Senior Director, Epidemiology & Real World Evidence
BioMarin Pharmaceutical Inc.
David Hinds, MHS, is a Senior Director of Epidemiology & Real World Evidence at BioMarin Pharmaceutical, where he is responsible for the design and implementation of real world evidence studies, including post-marketing safety and effectivness studies. David has 14 years of experience applying pharmacoepidemiologic methods to support drug development across a range of therapeutic indiciations, including multiple rare diseases at BioMarin.
Disclosure information not submitted.
Ensuring Patient Registries Support Regulatory Decision-Making
Wednesday, October 4, 2023
3:30 PM – 4:30 PM EDT